Illumina Inc Announces Patent Claim Construction Ruling In Litigation Against Complete Genomics, Inc

Illumina, Inc. announced that Magistrate Judge Elizabeth D. Laporte of the U.S. District Court for the Northern District of California issued a Claim Construction Order in the litigation brought by Illumina against Complete Genomics, Inc. Illumina has accused Complete Genomics of infringing U.S. Patent No. 6,306,597. Judge Laporte’s February 8 Order provides the Court’s interpretation of the disputed terms in the patent asserted by Illumina. In its Order, the Court adopted constructions favorable to Illumina for the key terms in dispute. Illumina believes that the Court’s interpretations affirm the breadth of the patent and Illumina’s position that Complete Genomics infringes the patent.